Global Hib Vaccine Market: Introduction

  • Haemophilus influenza type b (Hib) is a bacterium which causes several diseases such as pneumonia, epiglottitis, meningitis, and sepsis mostly in children younger than 5 years
  • In infants and young children, Hib disease can cause serious health issues. Infection can spread to different parts of the body — including the brain, throat, spinal cord, and lungs. These infections can even cause serious implication on child’s health; they can be deadly. For example, Hib meningitis causes brain damage or hearing loss in 1 in 5 children who survive it.
  • The Hib vaccine is the best way to protect the child from Hib disease
  • Two types of vaccines are available that can be used against Hib disease:
    • The Hib vaccine protects children and adults from Hib disease
    • The DTaP-IPV/Hib vaccine protects babies ranging from 2 to 18 months from Hib disease, tetanus, diphtheria, whooping cough, and polio

Key Drivers of Global Hib Vaccine Market

  • Numerous initiatives taken by governments and private organizations, for example, GAVI combined with the WHO activity to present the haemophilus influenzae type B disease into global immunization programs, are expected to drive the market. Because of the initiative, 80% of the GAVI covered countries have effectively provided the vaccine. These initiatives helped provide immunization to low income countries at a nominal rate, because of which these vaccines are made accessible worldwide.
  • The different initiatives taken up by organizations in the healthcare sector to give better medicines coupled with research and development are anticipated to add to the growth of the market during the forecast period
  • According to the American Medical Association, due to Hib, approximately 30,000 deaths occur in children aged between 1 to 23 months. The mortality rate caused by Hib is likely to drive the demand for Hib Vaccine, as the vaccine is the best way to protect the infants and young children from infection.

Are you a Start-up willing to make it big in the Business? Grab an Exclusive PDF Brochure of Hib Vaccine Market Report

Restraints of Global Hib Vaccine Market

  • High prices of vaccine are projected to hamper the growth of the global Hib vaccine market. For example, average cost of DTap-IP-HI vaccine is US$ 96. Prices can vary from $50 to $200 per vaccine. The high price is expected to hinder the growth of the market in the emerging economies, especially those countries which are not a part of international initiatives.
  • These vaccines have limited shelf life, combined with explicit storage conditions for containing these liquid monovalent Hib vaccines that cannot be permitted to freeze, simultaneously should be stored in temperatures between 2?C to 4?C
  • Additionally, patients may have hypersensitivity to certain substances that is anticipated to decrease the demand and is assessed to restrain the market in the next few years

North America to Lead Global Hib Vaccine Market

  • In terms of region, the global Hib vaccine market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America dominated the global Hib vaccine market, owing to large investment in healthcare sector and continuous research & development. Increase in government initiated vaccination program is expected to fuel the growth of the Hib vaccine market in North America.
  • Europe is the second largest market for Hib vaccination due to high adoption of the immunization. Almost all the member countries of Europe have implemented Hib vaccine as a part of infant immunization program.
  • The market in Asia Pacific is expected to grow at a high pace during the forecast period due to rise in adoption of vaccine and increased awareness of immunization. A few countries such as China and India are involved in developing vaccines.
  • Regions such as Latin America and Middle East & Africa are anticipated to be lucrative markets for Hib vaccine during the forecast period due to various international initiatives taking place and upgraded health care facilities

Expanding Operations in Future? To Get the Perfect Launch Ask for a Custom Hib Vaccine Market Report

Key Players Operating in Global Hib Vaccine Market

  • GlaxoSmithKline plc
  • Sanofi
  • Merck Sharp & Dohme Corp
  • Takeda Pharmaceutical Company Limited
  • Novartis AG
  • Bharat Biotech
  • Serum Institute of India Pvt. Ltd
  • BIO-MED
  • Panacea Biotec Ltd
  • LG Chem
  • Biological E Limited

Global Hib Vaccine Market: Research Scope

Global Hib Vaccine Market, by Type

  • Type 1-Hib Vaccine
  • Type 2- DTaP-IPV

Global Hib Vaccine Market, by Formulation

  • Liquid Monovalent Hib
  • Liquid Combination Hib
  • Lyophilized Monovalent Hib
  • Lyophilized Combination Hib

Global Hib Vaccine Market, by Distribution Channel

  • Hospitals & Clinics
  • Retail Pharmacies
  • Online Pharmacies
  • Others 

Global Hib Vaccine Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market

Note:Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Hib Vaccine Market

Pre Book